TEL AVIV -- Elan Corp., the Dublin drugmaker, swung to a fourth-quarter loss from a year-earlier profit on 11% higher revenue, and it said that in 2010 it expects to report operating profit before charges or gains for the first time. The quarterly ... Read Full Story